期刊文献+

从Cohn法组份Ⅳ中分离纯化人血浆蛋白C 被引量:2

Isolation and purification of human protein C from Cohn Fraction Ⅳ
下载PDF
导出
摘要 目的探索建立1种串联离子交换层析和固相化金属螯合亲和层析从Cohn法组份Ⅳ分离纯化蛋白C的方法 ,降低纯化蛋白C的成本,并实现血浆的综合利用。方法 4℃条件下,将Cohn法组份Ⅳ用PBS缓冲液抽提5h,离心(6500g)40min,上清液依次用0.45μm和0.22μm的滤膜过滤后,超滤透析;再通过串联离子交换层析和固相化金属螯合亲和层析,对蛋白C进行纯化。通过SDS-PAGE鉴定蛋白C的纯度;用考马斯亮蓝法通过紫外分光光度计测定总蛋白含量;通过WHO指定的发色底物法和凝固法(一期法)测定蛋白C活性。结果纯化的蛋白C在SDS-PAGE图谱上呈现1条62kD左右的蛋白带;经过离子交换层析,蛋白C的活性回收率为(48.19±9.22)%,纯化倍数为(3.75±0.56)倍;固相化金属螯合亲和层析后,蛋白C活性回收率为(59.61±5.59)%,纯化倍数为(36.79±3.72)倍;蛋白C总活性回收率为(28.77±9.45)%,纯化倍数为(136.64±6.82)倍,比活性为(11.70±0.89)IU/mg。结论串联离子交换层析和固相化金属螯合亲和层析可以从Cohn法组份Ⅳ中获得比活性较高的蛋白C浓缩物。 Objective To establish a more inexpensive method for isolating and purifying protein C from Cohn Fraction Ⅳ by combining ion exchange chromatography and immobilized metal affinity chromatography, and to achieve an improved utilization of fresh frozen plasma.Methods Cohn Fraction Ⅳ was dissolved with phosphate buffered saline solution in a ratio of 1∶10 for 5 h at 4 ℃, and the suspension was centrifuged for 40 min(4 ℃,6 500 g). The supernatant was loaded through 0.45μm and 0.22μm filters in turn, and then ultrafiltered and dialyzed. Protein C was purified further via ion exchange chromatography and immobilized metal affinity chromatography. Characterization of protein C was performed by SDS-PAGE. Total protein content was determined by Bradford under UV absorption at 595 nm. The activity of protein C was determined using chromogenic substrate assay and one-stage clotting assay referenced against the World Health Organization International Standard. Results The purified protein C concentrate showed only one protein band on gels by SDS-PAGE, of which the molecular weight was ca. 62kD.The ion exchange chromatography step achieved a(3.75±0.56) fold increase in specific activity over the initiating material at a (48.19±9.22)% yield; and the immobilized metal affinity chromatography step achieved an additional (36.79±3.72) fold purification and a (59.61±5.59) % yield. Thus, an overall (136.64±6.82) fold increase in purity and a (28.77±9.45) % yield was obtained; protein C :C had a specific activity of (11.70±0.89) IU/mg protein. Conclusion The combination of ion exchange chromatography and immobilized metal affinity chromatography which is much less expensive could be an efficient method for protein C purification from Cohn Fraction Ⅳ.
出处 《中国输血杂志》 CAS CSCD 北大核心 2010年第5期355-360,共6页 Chinese Journal of Blood Transfusion
基金 四川省科技支撑计划项目(2009SZ0217)
关键词 Cohn法组份Ⅳ 蛋白C 分离 纯化 亲和层析 固相化金属螯合 比活性 Cohn Fraction Ⅳ Protein C Isolation Purification Immobilized metal affinity chromatography Specific activity
  • 相关文献

参考文献26

  • 1Kisiel W. Human plasma protein C. J Clin Invest, 1979, 64 (3) :761-769.
  • 2Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem, 1989, 264(9) :4743- 4746.
  • 3Esmon CT. The normal role of activated protein C in maintaining homeostasis and its relevance to critical illness. Crit Care,2001, 5(Suppl 2) :7-12.
  • 4Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med,2001, 29(7) :S48-S51.
  • 5Yeh CH, Chen ZC, Hsu CC, et al. Protection in rats with heatstroke: hyperbaric oxygen vs activated protein C therapy. Eur J Pharmacol,2010,635 ( 1-3 ) : 103-108.
  • 6Jiang JS, Chou HC, Wang LF, et al. Effects of activated protein C on ventilator-induced lung injury in rats [ J/OL]. Respiration, 2010-01-28 [2010-02-16]. http://www, ncbi. nlm. nih. gov/ pubmed/20110652.
  • 7Petraglia AL, Marky AH, Walker C, et al. Activated protein C is neuroprotective and mediates new blood vessel formation and neurogenesis after controlled cortical impact. Neurosurgery, 2010,66( 1 ) : 165-172.
  • 8Nandakemar R, Afshari H, Bruley DF. Analysis of equilibrium adsorption isotherms for human protein C purification by immobilized metal affinity chromatography. Adv Exp Med Biol, 2003, 540(25) :191-199.
  • 9Gaberc-Porekar V, Menart V. Perspectives of immobilized-metal affinity chromatography." J Biochem Biophys Methods, 2001, 49 ( 1-3 ) :335-360.
  • 10Lee JJ, Thiessen E, Bruley DF. Protein C production: metal ion/protein interracial interaction in immobilized metal affinity chromatography. Adv Exp Med Biol, 2005,566 (27) : 381-387.

同被引文献42

  • 1沈永才,孙文种,吕茂民,章金刚,倪道明,裴雪涛.人血浆蛋白C的纯化与鉴定[J].中国生物制品学杂志,2004,17(6):369-371. 被引量:3
  • 2穆成华,姚红娟,马光辉,连宾.肝素-琼脂糖凝胶6FF的制备及其在抗凝血酶III分离纯化中的应用[J].过程工程学报,2005,5(5):545-549. 被引量:9
  • 3Samama CM. Prothrombin complex concentrates :a brief review. EurJ Anaesthesiol,2008,25(10) :784-789.
  • 4Pejaudier L,KicKenin-Martin V,BofEa MC,et al. Appraisal of theprotein composition of prothrombin complex concentrates of differ-ent origins. Vox Sang, 1987,52(1-2) :1-9.
  • 5Pabinger I,Brenner B,Kalina U,et al. Prothrombin complex con-centrate (Beriplexw P/IS ) for emergency anticoagulation reversal :A prospective multinational clinical trial. J Thromb Haemost,2008,6(4) :622-631.
  • 6Leissinger CA, Blatt PM, Hoots WK, et al. Role of prothrombincomplex concentrates in reversing warfarin anticoagulation ; a reviewof the literature. Am J Hematol,2008,83(2) : 137-143.
  • 7Chistolini A, Mazzucconi MG, Tirindelli MC, et al. Disseminatedintravascular coagulation and myocardial infarction in a haemophil-ia B patient during therapy with prothrombin complex concen-trates. Acta Haematol, 1990,83(3) :163-165.
  • 8KaTayalcin G,Goldberg B,Cherrick 1,et al. Acute myocardial in-farction complicating prothrombin complex concentrate therapy inan 8-year-old boy with hemophilia A and factor V JH inhibitor. AmJ Pediatr Hematol Oncol,1993,15(4) :416-419.
  • 9Kbhler M,Hellstem P,Lechler E,et al. Thromboembolic complica-tions associated with the use of prothrombin complex and factor IXconcentrates. Thromb Haemost, 1998,80(3) : 399-402.
  • 10Majeed A,Eelde A,Agen A,et al.Thromboembolic safety and effi-cacy of prothrombin complex concentrates in the emergency reversalof warfarin coagulopathy. Thromb. Res. 2012,129(2) :146-151.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部